Clinical trial
EXPRESSO - European Carto® XP REgistry for Validating Specialized CFAE SOftware
NCT00812916 is registered in ClinicalTrials.gov with Biosense Webster EMEA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- EXPRESSO - European Carto® XP REgistry for Validating Specialized CFAE SOftware
- Lead sponsor
- Biosense Webster EMEA
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2008
- Completion date
- December 31, 2010
- Enrollment
- 206 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.